These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3215450)

  • 21. [Current diagnostics and therapy of the overactive bladder and urge incontinence].
    Badawi JK; Langbein S
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1503-6. PubMed ID: 15942840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of persistent detrusor overactivity after transvaginal sling procedures.
    Gamble TL; Botros SM; Beaumont JL; Goldberg RP; Miller JJ; Adeyanju O; Sand PK
    Am J Obstet Gynecol; 2008 Dec; 199(6):696.e1-7. PubMed ID: 18845297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recurrent urinary incontinence: cystomanometry--conditio sine qua non?].
    Madersbacher H; Ebner A
    Urologe A; 1986 Sep; 25(5):271-7. PubMed ID: 3787889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Obstruction following surgical repair of female stress urinary incontinence. Diagnosis and treatment].
    Romero Maroto J; Prieto Chaparro L; López López C; Quilez Fenoll JM; Rodríguez Fernández E
    Arch Esp Urol; 2002 Nov; 55(9):1107-14. PubMed ID: 12564070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An assessment of the surgical outcome and urodynamic effects of the pubovaginal sling for stress incontinence and the associated urge syndrome.
    Fulford SC; Flynn R; Barrington J; Appanna T; Stephenson TP
    J Urol; 1999 Jul; 162(1):135-7. PubMed ID: 10379756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Urodynamic results of Burch colposuspension].
    Schürmann R; Ralph G
    Zentralbl Gynakol; 1990; 112(9):577-81. PubMed ID: 2378188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intravesical administration of estriol as a possible form of therapy of sensory urge incontinence].
    Kurz C; Enzelsberger H; Adler A; Knogler W
    Gynakol Rundsch; 1991; 31 Suppl 2():326-7. PubMed ID: 1790968
    [No Abstract]   [Full Text] [Related]  

  • 29. Transvaginal urethrolysis for urethral obstruction after anti-incontinence surgery.
    Cross CA; Cespedes RD; English SF; McGuire EJ
    J Urol; 1998 Apr; 159(4):1199-201. PubMed ID: 9507832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical effects of clenbuterol-HCL in urge incontinence and stress incontinence].
    Yamanishi T; Yasuda K; Nagashima K; Naoto ; Murayama ; Tojo M; Shimazaki J
    Hinyokika Kiyo; 1990 Feb; 36(2):207-11. PubMed ID: 2343815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urodynamic effects of intravesical instillation of lidocaine in patients with overactive detrusor.
    Yokoyama O; Ishiura Y; Nakamura Y; Kunimi K; Mita E; Namiki M
    J Urol; 1997 May; 157(5):1826-30. PubMed ID: 9112532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vaginal estriol administration in treatment of postmenopausal urinary incontinence].
    Schmidbauer CP
    Urologe A; 1992 Nov; 31(6):384-9. PubMed ID: 1462489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The etiology of post-radical prostatectomy incontinence and correlation of symptoms with urodynamic findings.
    Ficazzola MA; Nitti VW
    J Urol; 1998 Oct; 160(4):1317-20. PubMed ID: 9751344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia.
    Chartier-Kastler EJ; Ruud Bosch JL; Perrigot M; Chancellor MB; Richard F; Denys P
    J Urol; 2000 Nov; 164(5):1476-80. PubMed ID: 11025686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urodynamic classification of patients with symptoms of overactive bladder.
    Flisser AJ; Walmsley K; Blaivas JG
    J Urol; 2003 Feb; 169(2):529-33; discussion 533-4. PubMed ID: 12544302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detrusor instability--an important but underestimated factor in urinary incontinence in women].
    Dimitrov R; Doganov N
    Akush Ginekol (Sofiia); 1998; 37(3):23-6. PubMed ID: 10204261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input.
    Silva C; Ribeiro MJ; Cruz F
    J Urol; 2002 Aug; 168(2):575-9. PubMed ID: 12131313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for stress, urge or mixed urinary incontinence in Italy.
    Parazzini F; Chiaffarino F; Lavezzari M; Giambanco V;
    BJOG; 2003 Oct; 110(10):927-33. PubMed ID: 14550363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor.
    Hoebeke P; De Caestecker K; Vande Walle J; Dehoorne J; Raes A; Verleyen P; Van Laecke E
    J Urol; 2006 Jul; 176(1):328-30; discussion 330-1. PubMed ID: 16753434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of long-term safety and clinical benefit of terodiline in women with urgency/urge incontinence. A multicentre study.
    Fischer-Rasmussen W
    Scand J Urol Nephrol Suppl; 1984; 87():35-47. PubMed ID: 6443541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.